Vivo Capital, LLC Kala Pharmaceuticals, Inc. Transaction History

Vivo Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$5.06 - $8.15 $3.98 Million - $6.41 Million	-786,883 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$3.83 - $8.79 $3.01 Million - $6.92 Million	786,883 New	786,883 $6.92 Million
Q3 2019 Nov 13, 2019	SELL	$3.57 - $6.58 $3.72 Million - $6.86 Million	-1,043,020 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$12.26 - $18.98 $1.42 Million - $2.2 Million	-115,891 Reduced 10.0%	1,043,020 $16.5 Million
Q3 2017 Nov 13, 2017	BUY	$19.86 - $26.53 $23 Million - $30.7 Million	1,158,911	1,158,911 $26.5 Million

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $10.7M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Vivo Capital, LLC with notifications on news.